Broad-Based Genomic Testing May Have No Effect On Overall Survival Among Patients With Non-Small Cell Lung Cancer, Study Suggests.

August 08, 2018

MedPage Today (8/7, Bankhead) reports researchers found “broad-based genomic testing had little influence on treatment decisions, and no effect on overall survival, among patients with non-small cell lung cancer (NSCLC) treated in the community.” The fin...